EMS-CHEMIE HOLDING AG (EMSN) - Net Assets
Based on the latest financial reports, EMS-CHEMIE HOLDING AG (EMSN) has net assets worth CHF1.86 Billion CHF (≈ $2.35 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CHF2.23 Billion ≈ $2.81 Billion USD) and total liabilities (CHF368.02 Million ≈ $465.28 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check EMSN intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CHF1.86 Billion |
| % of Total Assets | 83.47% |
| Annual Growth Rate | 1.5% |
| 5-Year Change | 1.65% |
| 10-Year Change | 30.17% |
| Growth Volatility | 9.63 |
EMS-CHEMIE HOLDING AG - Net Assets Trend (2002–2025)
This chart illustrates how EMS-CHEMIE HOLDING AG's net assets have evolved over time, based on quarterly financial data. See how many days can EMS-CHEMIE HOLDING AG fund operations to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for EMS-CHEMIE HOLDING AG (2002–2025)
The table below shows the annual net assets of EMS-CHEMIE HOLDING AG from 2002 to 2025. For live valuation and market cap data, see EMS-CHEMIE HOLDING AG market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CHF1.86 Billion ≈ $2.35 Billion |
-0.33% |
| 2024-12-31 | CHF1.86 Billion ≈ $2.36 Billion |
+5.43% |
| 2023-12-31 | CHF1.77 Billion ≈ $2.24 Billion |
-4.11% |
| 2022-12-31 | CHF1.84 Billion ≈ $2.33 Billion |
+0.88% |
| 2021-12-31 | CHF1.83 Billion ≈ $2.31 Billion |
+12.56% |
| 2020-12-31 | CHF1.62 Billion ≈ $2.05 Billion |
-3.64% |
| 2019-12-31 | CHF1.69 Billion ≈ $2.13 Billion |
+2.49% |
| 2018-12-31 | CHF1.64 Billion ≈ $2.08 Billion |
+6.08% |
| 2017-12-31 | CHF1.55 Billion ≈ $1.96 Billion |
+8.59% |
| 2016-12-31 | CHF1.43 Billion ≈ $1.81 Billion |
+8.84% |
| 2015-12-31 | CHF1.31 Billion ≈ $1.66 Billion |
+3.44% |
| 2014-12-31 | CHF1.27 Billion ≈ $1.60 Billion |
+5.74% |
| 2013-12-31 | CHF1.20 Billion ≈ $1.52 Billion |
+4.18% |
| 2012-12-31 | CHF1.15 Billion ≈ $1.46 Billion |
+8.96% |
| 2011-12-31 | CHF1.06 Billion ≈ $1.34 Billion |
-4.85% |
| 2010-12-31 | CHF1.11 Billion ≈ $1.40 Billion |
+8.68% |
| 2009-12-31 | CHF1.02 Billion ≈ $1.29 Billion |
+4.76% |
| 2008-12-31 | CHF975.30 Million ≈ $1.23 Billion |
-23.60% |
| 2007-12-31 | CHF1.28 Billion ≈ $1.61 Billion |
+15.77% |
| 2006-12-31 | CHF1.10 Billion ≈ $1.39 Billion |
+1.83% |
| 2005-12-31 | CHF1.08 Billion ≈ $1.37 Billion |
-3.16% |
| 2004-12-31 | CHF1.12 Billion ≈ $1.41 Billion |
-24.25% |
| 2003-12-31 | CHF1.48 Billion ≈ $1.87 Billion |
+11.84% |
| 2002-12-31 | CHF1.32 Billion ≈ $1.67 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to EMS-CHEMIE HOLDING AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 63.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CHF2.06 Billion | 111.14% |
| Common Stock | CHF234.00K | 0.01% |
| Other Comprehensive Income | CHF-206.85 Million | -11.15% |
| Total Equity | CHF1.85 Billion | 100.00% |
EMS-CHEMIE HOLDING AG Competitors by Market Cap
The table below lists competitors of EMS-CHEMIE HOLDING AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Banco Bradesco S.A.
SA:BBDC3
|
$15.69 Billion |
|
BK OF IREL.UNSP.ADR/1 EO1
F:BIRB
|
$15.70 Billion |
|
BANC.DE.SA.A ADR2/EO-125
F:BDS
|
$15.71 Billion |
|
SK Holdings 1p Pref
KO:03473K
|
$15.74 Billion |
|
ASSOC. BR. FOODS ADR 1
F:AFO2
|
$15.67 Billion |
|
Leidos Holdings Inc
NYSE:LDOS
|
$15.64 Billion |
|
Brambles Ltd
AU:BXB
|
$15.63 Billion |
|
Shengyi Electronics Co. Ltd. A
SHG:688183
|
$15.63 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in EMS-CHEMIE HOLDING AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,834,940,000 to 1,854,901,000, a change of 19,961,000 (1.1%).
- Net income of 467,000,000 contributed positively to equity growth.
- Dividend payments of 403,461,000 reduced retained earnings.
- Other comprehensive income decreased equity by 8,596,001.
- Other factors decreased equity by 34,981,999.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CHF467.00 Million | +25.18% |
| Dividends Paid | CHF403.46 Million | -21.75% |
| Other Comprehensive Income | CHF-8.60 Million | -0.46% |
| Other Changes | CHF-34.98 Million | -1.89% |
| Total Change | CHF- | 1.09% |
Book Value vs Market Value Analysis
This analysis compares EMS-CHEMIE HOLDING AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 9.00x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 14.45x to 9.00x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | CHF49.40 | CHF714.00 | x |
| 2003-12-31 | CHF55.23 | CHF714.00 | x |
| 2004-12-31 | CHF44.56 | CHF714.00 | x |
| 2005-12-31 | CHF39.15 | CHF714.00 | x |
| 2006-12-31 | CHF41.80 | CHF714.00 | x |
| 2007-12-31 | CHF52.32 | CHF714.00 | x |
| 2008-12-31 | CHF41.95 | CHF714.00 | x |
| 2009-12-31 | CHF44.91 | CHF714.00 | x |
| 2010-12-31 | CHF47.16 | CHF714.00 | x |
| 2011-12-31 | CHF44.53 | CHF714.00 | x |
| 2012-12-31 | CHF48.59 | CHF714.00 | x |
| 2013-12-31 | CHF50.68 | CHF714.00 | x |
| 2014-12-31 | CHF53.47 | CHF714.00 | x |
| 2015-12-31 | CHF55.18 | CHF714.00 | x |
| 2016-12-31 | CHF60.09 | CHF714.00 | x |
| 2017-12-31 | CHF65.20 | CHF714.00 | x |
| 2018-12-31 | CHF69.48 | CHF714.00 | x |
| 2019-12-31 | CHF71.09 | CHF714.00 | x |
| 2020-12-31 | CHF68.31 | CHF714.00 | x |
| 2021-12-31 | CHF76.91 | CHF714.00 | x |
| 2022-12-31 | CHF77.63 | CHF714.00 | x |
| 2023-12-31 | CHF74.47 | CHF714.00 | x |
| 2024-12-31 | CHF78.45 | CHF714.00 | x |
| 2025-12-31 | CHF79.31 | CHF714.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently EMS-CHEMIE HOLDING AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 25.18%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 23.95%
- • Asset Turnover: 0.88x
- • Equity Multiplier: 1.20x
- Recent ROE (25.18%) is above the historical average (24.70%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 12.79% | 12.33% | 0.42x | 2.46x | CHF36.00 Million |
| 2003 | 7.87% | 8.57% | 0.42x | 2.16x | CHF-30.76 Million |
| 2004 | 16.97% | 15.96% | 0.44x | 2.40x | CHF75.34 Million |
| 2005 | 17.01% | 14.13% | 0.53x | 2.26x | CHF73.01 Million |
| 2006 | 28.20% | 21.31% | 0.60x | 2.21x | CHF191.95 Million |
| 2007 | 23.32% | 18.31% | 0.70x | 1.81x | CHF167.80 Million |
| 2008 | 22.42% | 13.80% | 0.93x | 1.75x | CHF119.20 Million |
| 2009 | 22.02% | 18.73% | 0.69x | 1.70x | CHF120.74 Million |
| 2010 | 21.16% | 14.55% | 0.96x | 1.52x | CHF122.41 Million |
| 2011 | 23.25% | 14.61% | 1.01x | 1.57x | CHF138.01 Million |
| 2012 | 23.50% | 15.21% | 1.05x | 1.48x | CHF153.38 Million |
| 2013 | 26.81% | 16.55% | 1.10x | 1.47x | CHF199.13 Million |
| 2014 | 27.43% | 17.12% | 1.09x | 1.48x | CHF217.86 Million |
| 2015 | 29.16% | 19.48% | 1.02x | 1.47x | CHF247.22 Million |
| 2016 | 31.94% | 22.31% | 1.01x | 1.41x | CHF308.26 Million |
| 2017 | 31.58% | 22.12% | 1.04x | 1.38x | CHF329.02 Million |
| 2018 | 31.97% | 22.12% | 1.09x | 1.33x | CHF357.11 Million |
| 2019 | 31.70% | 24.49% | 0.97x | 1.33x | CHF360.87 Million |
| 2020 | 27.18% | 24.10% | 0.87x | 1.30x | CHF274.56 Million |
| 2021 | 30.59% | 24.42% | 0.97x | 1.29x | CHF370.43 Million |
| 2022 | 29.30% | 21.79% | 1.05x | 1.28x | CHF350.52 Million |
| 2023 | 26.27% | 20.90% | 1.01x | 1.24x | CHF283.40 Million |
| 2024 | 25.11% | 22.25% | 0.93x | 1.21x | CHF277.29 Million |
| 2025 | 25.18% | 23.95% | 0.88x | 1.20x | CHF281.51 Million |
Industry Comparison
This section compares EMS-CHEMIE HOLDING AG's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $2,469,971,000
- Average return on equity (ROE) among peers: 17.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| EMS-CHEMIE HOLDING AG (EMSN) | CHF1.86 Billion | 12.79% | 0.20x | $15.67 Billion |
| Clariant AG (CLN) | $2.55 Billion | 9.94% | 2.29x | $2.41 Billion |
| Givaudan SA (GIVN) | $2.77 Billion | 9.33% | 0.65x | $25.65 Billion |
| Gurit Holding AG (GURN) | $171.98 Million | 27.28% | 1.19x | $161.16 Million |
| Sika AG (SIKA) | $4.40 Billion | 23.84% | 1.48x | $25.37 Billion |
About EMS-CHEMIE HOLDING AG
EMS-CHEMIE HOLDING AG engages in the polymers and specialty chemicals businesses in the Americas, Europe, Asia, and internationally. It is involved in the manufacturing and supply of high-performance polyamide granulate, as well as develops, produces, and sells fibers, fusible adhesives, and adhesive yarns for technical and textile applications, powder coatings, and reactive diluents. The company… Read more